166 related articles for article (PubMed ID: 22868232)
1. Screening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatment.
Kauss T; Gaudin K; Gaubert A; Ba B; Tagliaferri S; Fawaz F; Fabre JL; Boiron JM; Lafarge X; White NJ; Olliaro PL; Millet P
Int J Pharm; 2012 Oct; 436(1-2):624-30. PubMed ID: 22868232
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical development and optimization of azithromycin suppository for paediatric use.
Kauss T; Gaubert A; Boyer C; Ba BB; Manse M; Massip S; Léger JM; Fawaz F; Lembege M; Boiron JM; Lafarge X; Lindegardh N; White NJ; Olliaro P; Millet P; Gaudin K
Int J Pharm; 2013 Jan; 441(1-2):218-26. PubMed ID: 23220079
[TBL] [Abstract][Full Text] [Related]
3. Effects of food on a gastrically degraded drug: azithromycin fast-dissolving gelatin capsules and HPMC capsules.
Curatolo W; Liu P; Johnson BA; Hausberger A; Quan E; Vendola T; Vatsaraj N; Foulds G; Vincent J; Chandra R
Pharm Res; 2011 Jul; 28(7):1531-9. PubMed ID: 21331473
[TBL] [Abstract][Full Text] [Related]
4. Development and optimization of controlled release bioerodable anti infective ophthalmic insert.
Thakur R; Swami G; Rahman M
Curr Drug Deliv; 2014; 11(1):2-10. PubMed ID: 22283654
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatine capsule formulations.
Honkanen O; Laaksonen P; Marvola J; Eerikäinen S; Tuominen R; Marvola M
Eur J Pharm Sci; 2002 Jun; 15(5):479-88. PubMed ID: 12036724
[TBL] [Abstract][Full Text] [Related]
6. The in vitro dissolution of theophylline from different types of hard shell capsules.
Podczeck F; Jones BE
Drug Dev Ind Pharm; 2002 Oct; 28(9):1163-9. PubMed ID: 12455475
[TBL] [Abstract][Full Text] [Related]
7. Development of doxycycline hyclate suppositories and pharmacokinetic study in rabbits.
Christ AP; Biscaino PT; Lourenço RL; de Souza AB; Zimmermann ES; Adams AIH
Eur J Pharm Sci; 2020 Jan; 142():105141. PubMed ID: 31706017
[TBL] [Abstract][Full Text] [Related]
8. Amorphous azithromycin with improved aqueous solubility and intestinal membrane permeability.
Aucamp M; Odendaal R; Liebenberg W; Hamman J
Drug Dev Ind Pharm; 2015; 41(7):1100-8. PubMed ID: 24980913
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of hard gelatin capsule shells filled with polyethylene glycol matrices.
Stein D; Bindra DS
Pharm Dev Technol; 2007; 12(1):71-7. PubMed ID: 17484146
[TBL] [Abstract][Full Text] [Related]
10. Preliminary pharmaceutical development of antimalarial-antibiotic cotherapy as a pre-referral paediatric treatment of fever in malaria endemic areas.
Gaubert A; Kauss T; Marchivie M; Ba BB; Lembege M; Fawaz F; Boiron JM; Lafarge X; Lindegardh N; Fabre JL; White NJ; Olliaro PL; Millet P; Grislain L; Gaudin K
Int J Pharm; 2014 Jul; 468(1-2):55-63. PubMed ID: 24726300
[TBL] [Abstract][Full Text] [Related]
11. Study on rectal administration of azithromycin by suppository for pediatric use.
Maeda M; Nakano Y; Aoyama T; Matsumoto Y; Fujito H
Int J Clin Pharmacol Ther; 2016 Apr; 54(4):263-8. PubMed ID: 26833461
[TBL] [Abstract][Full Text] [Related]
12. Hard gelatin and hypromellose (HPMC) capsules: estimation of rupture time by real-time dissolution spectroscopy.
El-Malah Y; Nazzal S; Bottom CB
Drug Dev Ind Pharm; 2007 Jan; 33(1):27-34. PubMed ID: 17192248
[TBL] [Abstract][Full Text] [Related]
13. A comparison of in vitro ADME properties and pharmacokinetics of azithromycin and selected 15-membered ring macrolides in rodents.
Milić A; Mihaljević VB; Ralić J; Bokulić A; Nožinić D; Tavčar B; Mildner B; Munić V; Malnar I; Padovan J
Eur J Drug Metab Pharmacokinet; 2014 Dec; 39(4):263-76. PubMed ID: 24114177
[TBL] [Abstract][Full Text] [Related]
14. Thermoresponsive gelatin/monomethoxy poly(ethylene glycol)-poly(D,L-lactide) hydrogels: formulation, characterization, and antibacterial drug delivery.
Yang H; Kao WJ
Pharm Res; 2006 Jan; 23(1):205-14. PubMed ID: 16270162
[TBL] [Abstract][Full Text] [Related]
15. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
Wu Y; Zhao F; Paborji M
Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
[TBL] [Abstract][Full Text] [Related]
16. MPEG-PCL Copolymeric Micelles for Encapsulation of Azithromycin.
Wei W; Li S; Xu H; Zhou F; Wen Y; Song Z; Feng S; Feng R
AAPS PharmSciTech; 2018 Jul; 19(5):2041-2047. PubMed ID: 29675667
[TBL] [Abstract][Full Text] [Related]
17. The shell dissolution of various empty hard capsules.
Chiwele I; Jones BE; Podczeck F
Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):951-6. PubMed ID: 10923822
[TBL] [Abstract][Full Text] [Related]
18. In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels.
Holland TA; Tabata Y; Mikos AG
J Control Release; 2003 Sep; 91(3):299-313. PubMed ID: 12932709
[TBL] [Abstract][Full Text] [Related]
19. Formulation development and human in vitro-in vivo correlation for a novel, monolithic controlled-release matrix system of high load and highly water-soluble drug niacin.
Turner S; Federici C; Hite M; Fassihi R
Drug Dev Ind Pharm; 2004 Sep; 30(8):797-807. PubMed ID: 15521326
[TBL] [Abstract][Full Text] [Related]
20. Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation.
Khan FN; Dehghan MH
AAPS PharmSciTech; 2011 Dec; 12(4):1077-86. PubMed ID: 21879394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
